121 related articles for article (PubMed ID: 20410929)
21. Interleukin 4 receptor expression and growth inhibition of gastric carcinoma cells by interleukin 4.
Morisaki T; Yuzuki DH; Lin RT; Foshag LJ; Morton DL; Hoon DS
Cancer Res; 1992 Nov; 52(21):6059-65. PubMed ID: 1394231
[TBL] [Abstract][Full Text] [Related]
22. Deficient tumor-specific immunity in old mice: in vivo mediation by suppressor cells, and correction of the defect by interleukin 2 supplementation in vitro but not in vivo.
Bruley-Rosset M; Payelle B
Eur J Immunol; 1987 Mar; 17(3):307-12. PubMed ID: 2952510
[TBL] [Abstract][Full Text] [Related]
23. Immunosuppressive myeloid-derived suppressor cells can be converted into immunogenic APCs with the help of activated NKT cells: an alternative cell-based antitumor vaccine.
Ko HJ; Lee JM; Kim YJ; Kim YS; Lee KA; Kang CY
J Immunol; 2009 Feb; 182(4):1818-28. PubMed ID: 19201833
[TBL] [Abstract][Full Text] [Related]
24. Interleukin 4 receptor on human lung cancer: a molecular target for cytotoxin therapy.
Kawakami M; Kawakami K; Stepensky VA; Maki RA; Robin H; Muller W; Husain SR; Puri RK
Clin Cancer Res; 2002 Nov; 8(11):3503-11. PubMed ID: 12429641
[TBL] [Abstract][Full Text] [Related]
25. A role for endogenous IL-12 in tumor immunity: IL-12 is required for the acquisition of tumor-migratory capacity by T cells and the development of T cell-accepting capacity in tumor masses.
Uekusa Y; Gao P; Yamaguchi N; Tomura M; Mukai T; Nakajima C; Iwasaki M; Takeuchi N; Tsujimura T; Nakazawa M; Fujiwara H; Hamaoka T
J Leukoc Biol; 2002 Nov; 72(5):864-73. PubMed ID: 12429708
[TBL] [Abstract][Full Text] [Related]
26. IL-4-dependent up-regulation of IL-4 receptor expression in murine T and B cells.
Renz H; Domenico J; Gelfand EW
J Immunol; 1991 May; 146(9):3049-55. PubMed ID: 2016538
[TBL] [Abstract][Full Text] [Related]
27. Expression of high-affinity interleukin 4 receptors on murine sarcoma cells and receptor-mediated cytotoxicity of tumor cells to chimeric protein between interleukin 4 and Pseudomonas exotoxin.
Puri RK; Ogata M; Leland P; Feldman GM; FitzGerald D; Pastan I
Cancer Res; 1991 Jun; 51(11):3011-7. PubMed ID: 2032239
[TBL] [Abstract][Full Text] [Related]
28. Endogenous interleukin-4 promotes tumor development by increasing tumor cell resistance to apoptosis.
Li Z; Jiang J; Wang Z; Zhang J; Xiao M; Wang C; Lu Y; Qin Z
Cancer Res; 2008 Nov; 68(21):8687-94. PubMed ID: 18974110
[TBL] [Abstract][Full Text] [Related]
29. Growth stimulation of human head and neck squamous cell carcinoma cell lines by interleukin 4.
Myers JN; Yasumura S; Suminami Y; Hirabayashi H; Lin Wc; Johnson JT; Lotze MT; Whiteside TL
Clin Cancer Res; 1996 Jan; 2(1):127-35. PubMed ID: 9816099
[TBL] [Abstract][Full Text] [Related]
30. Production of soluble IL-4 receptors by murine spleen cells is regulated by T cell activation and IL-4.
Chilton PM; Fernandez-Botran R
J Immunol; 1993 Dec; 151(11):5907-17. PubMed ID: 8245438
[TBL] [Abstract][Full Text] [Related]
31. A pivotal role for CC chemokine receptor 5 in T-cell migration to tumor sites induced by interleukin 12 treatment in tumor-bearing mice.
Uekusa Y; Yu WG; Mukai T; Gao P; Yamaguchi N; Murai M; Matsushima K; Obika S; Imanishi T; Higashibata Y; Nomura S; Kitamura Y; Fujiwara H; Hamaoka T
Cancer Res; 2002 Jul; 62(13):3751-8. PubMed ID: 12097285
[TBL] [Abstract][Full Text] [Related]
32. Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF.
Dolcetti L; Peranzoni E; Ugel S; Marigo I; Fernandez Gomez A; Mesa C; Geilich M; Winkels G; Traggiai E; Casati A; Grassi F; Bronte V
Eur J Immunol; 2010 Jan; 40(1):22-35. PubMed ID: 19941314
[TBL] [Abstract][Full Text] [Related]
33. Functional changes in myeloid-derived suppressor cells (MDSCs) during tumor growth: FKBP51 contributes to the regulation of the immunosuppressive function of MDSCs.
Kim YS; Kim YJ; Lee JM; Kim EK; Park YJ; Choe SK; Ko HJ; Kang CY
J Immunol; 2012 May; 188(9):4226-34. PubMed ID: 22474024
[TBL] [Abstract][Full Text] [Related]
34. In vivo elimination of CD25+ regulatory T cells leads to tumor rejection of B16F10 melanoma, when combined with interleukin-12 gene transfer.
Nagai H; Horikawa T; Hara I; Fukunaga A; Oniki S; Oka M; Nishigori C; Ichihashi M
Exp Dermatol; 2004 Oct; 13(10):613-20. PubMed ID: 15447721
[TBL] [Abstract][Full Text] [Related]
35. Inhibition by interleukin 4 of leukemia inhibitory factor-, interleukin 6-, and dexamethasone-induced differentiation of mouse myeloid leukemia cells: role of c-myc and junB proto-oncogenes.
Kasukabe T; Okabe-Kado J; Hozumi M; Honma Y
Cancer Res; 1994 Jan; 54(2):592-7. PubMed ID: 8275499
[TBL] [Abstract][Full Text] [Related]
36. Aptamer-mediated blockade of IL4Rα triggers apoptosis of MDSCs and limits tumor progression.
Roth F; De La Fuente AC; Vella JL; Zoso A; Inverardi L; Serafini P
Cancer Res; 2012 Mar; 72(6):1373-83. PubMed ID: 22282665
[TBL] [Abstract][Full Text] [Related]
37. Contribution of myeloid-derived suppressor cells to tumor-induced immune suppression, angiogenesis, invasion and metastasis.
Ye XZ; Yu SC; Bian XW
J Genet Genomics; 2010 Jul; 37(7):423-30. PubMed ID: 20659706
[TBL] [Abstract][Full Text] [Related]
38. Myeloid derived suppressor cells (MDSCs) can induce the generation of Th17 response from naïve CD4+ T cells.
Chatterjee S; Das S; Chakraborty P; Manna A; Chatterjee M; Choudhuri SK
Immunobiology; 2013 May; 218(5):718-24. PubMed ID: 22995935
[TBL] [Abstract][Full Text] [Related]
39. Arginase-1 is neither constitutively expressed in nor required for myeloid-derived suppressor cell-mediated inhibition of T-cell proliferation.
Bian Z; Abdelaal AM; Shi L; Liang H; Xiong L; Kidder K; Venkataramani M; Culpepper C; Zen K; Liu Y
Eur J Immunol; 2018 Jun; 48(6):1046-1058. PubMed ID: 29488625
[TBL] [Abstract][Full Text] [Related]
40. Dickkopf-related protein 1 (Dkk1) regulates the accumulation and function of myeloid derived suppressor cells in cancer.
D'Amico L; Mahajan S; Capietto AH; Yang Z; Zamani A; Ricci B; Bumpass DB; Meyer M; Su X; Wang-Gillam A; Weilbaecher K; Stewart SA; DeNardo DG; Faccio R
J Exp Med; 2016 May; 213(5):827-40. PubMed ID: 27045006
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]